Scoop: Amgen recruits renowned cancer drug investigator Jean-Charles Soria to lead a growing pipeline play
One of the pioneers in the complete overhaul of oncology R&D over the last 10 years is headed to Amgen.
The pharma giant put out the word on social media that Jean-Charles Soria, the director general of the storied Gustave Roussy Institute in France, is joining LA-based Amgen to lead the oncology therapeutic area as senior vice president.
Soria, who also held a top oncology post with AstraZeneca before returning to the institute at the beginning of 2020, tells us via email that he is “deeply excited” to be joining the company.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 117,800+ biopharma pros reading Endpoints daily — and it's free.